Baron & Budd President and Managing Shareholder Russell Budd, along with Shareholder and leader of the Environmental ...

The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global biological therapies market for cancer is expected to grow ...

The "Contract Manufacturing of Medical Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for contract manufacturing of medical devices is estimated ...

Global Market Data Report" has been added to ResearchAndMarkets.com's offering.The global market for nanocoating is projected to grow from an estimated $15.3 billion in 2025 to reach $33.2 billion by ...

The "Successful Medical Writing - from Protocol to CTD Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering.Success in the pharmaceutical industry ...

Global Markets" report has been added to ResearchAndMarkets.com's offering.The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 ...

Expects full-year 2026 LINZESS® U.S. net sales of $1.125 to $1.175 billion; total revenues of $450 to $475 million and adjusted EBITDA of greater than $300 million -- Ended Q4 2025 with greater than ...

The "Selecting the Best Scientific Journal for Your Research Training Course (Apr 13, 2026)" training has been added to ResearchAndMarkets.com's offering.This session offers a detailed guide to ...

The "The Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026)" training has been added to ResearchAndMarkets.com's offering.Working in the highly competitive pharmaceutical industry, with ...

Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment HAMBURG, DE / ACCESS Newswire / ...

The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations to ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug Administration's Center ...